Summary of Product Characteristics
last updated on the eMC:
27/05/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 27/05/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 21-Aug-2008 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
7. Marketing Authorisation holder
ADDRESS CHANGE TO:
Hospira UK LimitedQueensway
Royal Leamington Spa
Warwickshire
CV31 3RW
United Kingdom
8. Marketing authorisation number(s)
CHANGE TO:
PL 04515/0225
10. Date of revision of the text
DATE CHANGE:
21st August 2008
|
|
Updated on 01/02/2002 and displayed until 27/05/2009
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
|
Updated on 30/07/2001 and displayed until 01/02/2002
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
|
|
Updated on 22/09/2000 and displayed until 30/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 22/09/2000
|
Reasons for adding or updating:
|
|
|
|